These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Species-specific modulation of the mitochondrial permeability transition by norbormide.
    Author: Ricchelli F, Dabbeni-Sala F, Petronilli V, Bernardi P, Hopkins B, Bova S.
    Journal: Biochim Biophys Acta; 2005 Jun 30; 1708(2):178-86. PubMed ID: 15953474.
    Abstract:
    In the present study, we show that norbormide stimulates the opening of the permeability transition pore (PTP) in mitochondria from various organs of the rat but not of guinea pig and mouse. Norbormide does not affect the basic parameters that modulate the PTP activity since the proton electrochemical gradient, respiration, phosphorylation and Ca(2+) influx processes are only partially affected. On the other hand, norbormide induces rat-specific changes in the fluidity of the lipid interior of mitochondrial membranes, as revealed by fluorescence anisotropy of various reporter molecules. Such changes increase the PTP open probability through the internal Me(2+) regulatory site. The lack of PTP opening by norbormide is matched by a negligible perturbation of internal lipid domains in guinea pig and mouse, suggesting that the drug does not gain access to the matrix in the mitochondria from these species. Consistent with this interpretation, we demonstrate a preferential interaction of norbormide with the mitochondrial surface leading to alterations of the Me(2+) binding affinity for the external PTP regulatory site. Our findings indicate that norbormide affects Me(2+) binding to the regulatory sites of the PTP, and suggest that the drug could be taken up by a mitochondrial transport system unique to the rat. The characterization of the norbormide target may lead to a better understanding of the mechanisms underlying the mitochondrial PTP as well as to the identification of species-specific drugs that affect mitochondrial function.
    [Abstract] [Full Text] [Related] [New Search]